New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:49 EDTBRK.A, ICE, NYXNYSE received counter-bid with value below ICE offer, reportedly from Berkshire
In a regulatory filing this morning, IntercontinentalExchange (ICE) disclosed that during the run-up to its agreement to merge with NYSE Euronext (NYX), NYSE's advisers initiated contact with representatives of a large industrial and financial holding company, identified in the filing as “Company A,” that they believed would be interested in NYSE Euronext’s businesses. Company A presented an indicative proposal with a value lower than the ICE proposal, according to the filing, and Company A's proposal also required that NYSE Euronext must first sell its European derivatives business for a specified minimum price. According to CNBC's David Faber, Company A described in the filing is Berkshire Hathaway (BRK.A). In the filing, IntercontinentalExchange also said the agreed upon merger with NYSE is subject to the merger control jurisdiction of the national competition authorities in Portugal, Spain and the U.K. The companies stated they intend to request a referral of the merger to the European Commission, such that merger clearance is required from only the European Commission in the EU. ICE and NYSE expect to submit the notification form to the European Commission during the first half of 2013, the filing said. In morning trading, NYSE Euronext shares were virtually unchanged, while IntercontinentalExchange was up 18c, or 0.13%, to $135.00.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
11:01 EDTAAgilent partners with Weill Cornell Medical College for ALS research
Subscribe for More Information
August 17, 2015
17:48 EDTAAgilent says confident in delivering on margin expansion goals
On the company Q3 earnings conference call, Agilent said that it is confident in delivering on margin expansion goals. The company noted that it is committed to a 22% operating margin by 2017 and will continue its buybacks in Q4. The company sees a number of areas of strength including Pharma, Life Science, Research and Diagnostics. The company is seeing double-digit growth in Pharma and has no reason to believe it will slow down. Agilent sees "a lot " of reasons to be positive on outlook.
16:21 EDTAAgilent says some U.S. and state government large deals delayed into Q4
Agilent said in a slides presentation that some US and state government large deals delayed into Q4. Customers in industrial markets continue cautious stance in light of macro-economic conditions.
16:09 EDTAAgilent narrows FY15 EPS view to $1.68-$1.72 from $1.67- $1.73
Subscribe for More Information
16:07 EDTAAgilent sees Q4 EPS 45c-49c, consensus 50c
Sees Q4 revenue $1.03B-$1.05B, consensus $1.06B.
16:06 EDTAAgilent reports Q3 EPS 44c, consensus 41c
Subscribe for More Information
14:48 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Agilent (A), consensus 41c... Urban Outfitters (URBN), consensus 49c... MasTec (MTZ), consensus 15c... Fabrinet (FN), consensus 39c.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use